Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Dutch Cancer Society and Schering AG (Netherlands)
Woman and Man Max 99 years
Dutch Cancer Society and Schering AG (Netherlands)
Update Il y a 4 ans
A randomized phase III study in previously untreated patients with biological high-risk CLL: fludarabine and cyclophosphamide (FC) versus FC and low-dose alemtuzumab
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
